Retroperıtoneal Soft-Tıssue Sarcomas

Status Completed

Clinical Trial Summary

: Soft Tissue Sarcomas are rare mesenchymal tumors with many subtypes. Clean margin-wide resection is recommended for treatment. The guidelines recommend that sarcoma treatments be carried out in sarcoma centers. In this study, the location, histopathological features, clinical and demographic features, recurrence, and prognosis of retroperitoneal sarcomas were investigated.

Clinical Trial Description

The demographic, histopathological, and immunohistochemical data of the patients who were operated on with the diagnosis of intraabdominal mass at Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital from March 2016 to December 2020 were retrospectively evaluated. Ethical approval was obtained from Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital Ethics Committee. Patients diagnosed with pathological sarcoma subclass were included in the study. Patients younger than 18 years were excluded from the study. Visceral organ-origin sarcomas and extremity sarcomas were also excluded from the study. GIST's were included in sarcoma subtypes by WHO in 2013. However, they were not included in the study due to their solid organ origin. The data of 18 patients' whore remained after the exclusion criteria were analyzed retrospectively. Pathology samples of the patients were re-examined by a single pathologist. The demographic analysis was used for statistics. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05044624
Study type	Interventional
Source	Istanbul Medeniyet University
Contact
Status	Completed
Phase	N/A
Start date	March 1, 2016
Completion date	June 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03838718` - REtroperitoneal SArcoma Registry: an International Prospective Initiative
Enrolling by invitation	`NCT05844813` - Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma	Phase 4
Terminated	`NCT00901836` - Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma	N/A
Active, not recruiting	`NCT04189783` - Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial)	Phase 2
Completed	`NCT04225494` - Perioperative Residual Adrenal Function After Extended Resection for Retroperitoneal Soft Tissue Sarcomas
Active, not recruiting	`NCT03792867` - Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma	N/A
Not yet recruiting	`NCT06025747` - Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma	Phase 1
Active, not recruiting	`NCT04224948` - The PET- Retroperitoneal Sarcoma Study	N/A
Recruiting	`NCT04031677` - Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma	Phase 3
Recruiting	`NCT05224934` - Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma	Phase 2
Completed	`NCT03877588` - Nutritional Status in Retroperitoneal Sarcoma.	N/A
Completed	`NCT02384473` - Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma	Early Phase 1
Withdrawn	`NCT05302570` - Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS	Phase 2
Recruiting	`NCT01659203` - Proton or Photon RT for Retroperitoneal Sarcomas	Phase 1/Phase 2
Recruiting	`NCT05631379` - Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma
Recruiting	`NCT06327477` - Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma	Phase 1/Phase 2